Homology Medicines, Inc.
NASDAQ:FIXX
0.9347 (USD) • At close March 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -47.733 | -112.961 | -5.005 | -95.764 | -128.694 | -103.916 | -57.215 | -29.991 | -8.047 |
| Depreciation & Amortization
| -0.027 | 0.578 | 1.293 | 8.353 | 7.965 | 6.318 | 1.289 | 0.684 | 0.24 |
| Deferred Income Tax
| 0 | 0 | 0 | 1.027 | 0.69 | 0 | 0 | -0.086 | 0 |
| Stock Based Compensation
| 4.386 | 7.324 | 13.054 | 17.245 | 13.248 | 7.635 | 2.623 | 0.277 | 0.162 |
| Change In Working Capital
| 0 | -7.209 | 3.35 | -41.803 | 11.52 | 0.463 | 12.203 | 34.718 | 0.928 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.043 | 2.09 | -0.981 | -2.487 | 2.459 | -4.452 | 4.383 | 1.72 | 0.518 |
| Other Working Capital
| 0 | -9.299 | 4.331 | -39.316 | 9.061 | 4.915 | 7.82 | 32.998 | 0.411 |
| Other Non Cash Items
| 0 | 18.128 | -126.353 | 1.191 | 0.939 | -1.858 | -1.462 | 0.876 | -1.768 |
| Operating Cash Flow
| -67.715 | -96.23 | -113.661 | -109.751 | -94.332 | -91.358 | -42.562 | 6.479 | -8.484 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -0.075 | -0.228 | -1.285 | -2.396 | -3.733 | -21.833 | -24.939 | -1.958 | -1.989 |
| Acquisitions Net
| 0 | 0 | 130 | 48.392 | -208.629 | 29.966 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -73.24 | -157.46 | -97.392 | -19.991 | -286.391 | -245.328 | -78.071 | 0 |
| Sales Maturities Of Investments
| 20 | 174.24 | 65.461 | 49 | 228.62 | 256.425 | 148.48 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 38.001 | -48.392 | 208.629 | -29.966 | 0 | -1.497 | -0.276 |
| Investing Cash Flow
| 19.925 | 101.326 | 36.716 | -50.788 | 204.896 | -51.799 | -121.787 | -81.526 | -2.265 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 42 | 0.184 | 0 | 0 | 0 | 0 | 0 | 0 | 0.378 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.017 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 53.138 | 0.184 | 0.596 | 52.169 | 53.093 | 158.213 | 150.994 | 115.23 | 0.378 |
| Financing Cash Flow
| 95.138 | 0.184 | 0.596 | 52.169 | 53.093 | 158.213 | 150.994 | 115.23 | 0.378 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 47.348 | 5.28 | -76.349 | -108.37 | 163.657 | 15.056 | -13.355 | 40.183 | -10.371 |
| Cash At End Of Period
| 78.612 | 39.266 | 33.986 | 110.335 | 218.705 | 55.048 | 38.22 | 51.575 | 11.392 |